AI is enabling the development of a next generation of drugs that can more precisely target cancer cells while sparing ...

A newly developed radiolabeled antibody that targets the cancer antigen IL13Rα2 has been found to be highly specific, binding only to cancer cells and not to the related antigen IL13Rα1, which is ...

To treat glioblastoma, Purdue researchers are developing antibody-based immunotherapies to improve the recruitment and ...

Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

“The advantage of using T–DM1 is that you considerably improve the therapeutic index because the antibody delivers the chemotherapy directly to the cancer cell. Also, because DM1 is tethered ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a ...

New research reveals 5 ways exercise enhances cancer treatment effectiveness, offering hope to patients with chronic ...

This study provides proof-of-principle data for the use of trained immunity to modulate macrophage interactions with tumours. The study makes a valuable contribution to the field of trained immunity.

Get Instant Summarized Text (Gist) A novel antibody therapy using IgE, rather than the conventional IgG, shows potential in treating ovarian cancer by reactivating immune cells. The IgE antibody ...

The trial’s novel approach uses Affimed’s AFM13 bispecific antibody ... Sally Cooper Murray Endowed Chair in Cancer Research, professor of Stem Cell Transplantation & Cellular Therapy ...